Exane Derivatives’s Tenet Healthcare THC Stock Holding History

Exane Derivatives’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,889	Closed	-$126K	–	977
2021 Q3	$126K	Buy	+1,889	New	+$134K	0.03%	493

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Exane Derivatives's THC Position: Q4 2021 in Review

Exane Derivatives sold out of Tenet Healthcare (THC) in Q4 2021, closing a stake of 1,889 shares — an estimated $126K sold.

Exane Derivatives first reported a position in THC in Q3 2021 and held it in 1 quarter. The position peaked at $126K in Q3 2021. 373 funds tracked by Wall St. Rank hold THC as of Q4 2021.

Exane Derivatives reported no remaining Tenet Healthcare position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 1,889 Tenet Healthcare shares in Q4 2021, an estimated $126K.
Exane Derivatives first reported a position in Tenet Healthcare in Q3 2021 and held it in 1 quarter.
Exane Derivatives's Tenet Healthcare position peaked at $126K in Q3 2021.
373 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.